AKT1 and fragile X syndrome: In regard to how inhibition of PDE affects the known signaling alteration such as ERK/12 and Akt, our data show that targeting PDE2 dampens the elevated Akt activity but further increases the elevated ERK1⁄2 activity in FXS.